The Global Liposome Drug Delivery market industry is witnessing significant growth driven by the increasing demand for targeted drug delivery systems. US, NY, UNITED STATES, February 13 ...

As a result, the liposome platform holds tremendous promise in the future of targeted cancer therapeutics to improve drug delivery while minimizing unwanted systemic bystander effects. This review ...

Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the ...

liposome properties, such as size, surface charge and functionality, can be easily tuned. Polymeric nanocarriers can be categorized based on three drug-incorporation mechanisms. The first includes ...

CNW/ -- (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and ...

In the pharmaceuticals sector, it has developed a CBD-loaded liposome drug delivery platform for non-opioid pain management. In the wellness sector, Innocan markets a wide range of self-care and ...

Israel: Innocan Pharma Corporation has announced that it has been granted a patent in India covering a prolonged-release ...

Innovative Chronic Pain Treatment Receives IP Protection in India's $55 Billion Pharmaceutical Market HERZLIYA, Israel and CALGARY, AB, Feb. 18, 2025 /PRNewswire/ -- Innocan Pharma ...

Developed jointly in collaboration with Professor Chezy Barenholz and Dr. Ahuva Cern from the Hebrew University in Jerusalem, the liposomal drug delivery platform allows for prolonged exposure and ...